Clinical Trial Update: Pharmacokinetics and Pharmacodynamics of Sugammadex in Reversal of Vecuronium-induced Neuromuscular Blockade [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the pharmacokinetics and pharmacodynamics of sugammadex in reversing vecuronium-induced neuromuscular blockade.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuromuscular Blockade Reversal

Drugs mentioned

• Sugammadex (sugammadex)
• Vecuronium (vecuronium bromide)

Snippet

Sponsor: Guangzhou General Hospital of Guangzhou Military Command | Conditions: Pharmacokinetics, Pharmacodynamics | Phase 4 | Status: UNKNOWN